The following sessions are considered special because they highlight an important collaboration or they have an honorary nature.
Opening & Fellowships Ceremony
On Friday afternoon the EHA President will officially open the 18th Congress and welcome all delegates, program contributors and sponsors to Stockholm. This plenary moment is also an excellent occasion to announce and honor the recipients of the 2013 Fellowship Program.
José Carreras Award and Lecture
The José Carreras Award was established to honor leading figures in hematological research and will be presented to an active investigator who has made a large contribution to hematology. This year the award will be handed to a basic scientist, who will also give the prestigious José Carreras Lecture.
The annual Business Meeting has been moved to Saturday lunch time (12:45 – 13:15), during which the EHA Board presents the highlights of the past year and looks ahead to EHA’s future.
Jean Bernard Lifetime Achievement Award
The EHA Jean Bernard Lifetime Achievement Award will be ceremoniously handed to the 5th winner for his/her lifetime contribution to the advancement of hematology during the Presidential Symposium on Saturday.
Presidential Symposium - Best Abstracts
The authors of the highest impact and quality abstracts will present their work during the Symposium bringing attendees up to speed on the latest research and clinical trials.
EHA Scientific Working Groups
Over the years, SWG sessions at the Annual Congress have seen a strong development and a substantial increase of participants. To support high-quality science, EHA kindly invites approved Scientific Working Groups to submit a program for a Scientific Session at the EHA Annual Congress. These sessions will take place simultaneously on Thursday evening from 18:30 – 20:00. Besides this regular feature during the congress the SPC has again opened up the possibility for SWG’s to provide a proposal for a Hematology-in-Focus session during the invited speaker program. Time slots for both sessions are given based on the scientific merit and contribution to the scientific congress program. The proposed programs are reviewed and approved by the Scientific Program Committee (SPC).
The following SWG’s are organizing programs at the 18th Congress:
- Acute myeloid leukemia
- Session title: AML in a rapidly evolving era
- Chronic myeloid leukemia
- New themes in CML
- ESLHO-EuroMRD and ESLHO-EuroFlow
- Session title: ESLHO for innovation and standardization of laboratory diagnostics
- European MCL Network
- Session title: Current study concepts of the European MCL Network
- European Research Initiative on CLL
- Session title:Welcoming a new era in CLL therapy
- European Working Group for Adult ALL
- Session title: Treatment of Adult and Elderly ALL Patients in the European ALL Trials
- European Working Group for Stem Cells
- Session title: iPS generation to study hematopoietic malignancies
- Granulocyte and monocyte disorders
- Session title: Myeloid (and other) cells: from pathophysiology to disease
- Hematological Pharmacology
- Session title: Hematological Pharmacology
- Leukemia diagnosis: morphology and flow cytometry
- Session title: Morphology and cytometry
- Myelodysplastic syndromes
- Session title: Management of cytopenias and their consequences in lower risk MDS
- Myeloproliferative disorders
- Session title: Scientific and clinical advances in Myeloproliferative Neoplasms: myths, facts and perspectives
- Multiple myeloma
- Session title:Models for drug resistance in multiple myeloma
- Quality of life and symptoms
- Session title:Implementation of treatment related patient-reported outcomes in routine clinical practice in hematological malignancies
- Red cell and iron
- Session title: Red Cells and Iron Disorders
- Thrombocytopenias and platelet function disorders
- Session title: Novel insights into the pathogenesis and management of thrombocytopenias and disorders of platelet function
EHA organizes several joint symposia with important partners in its hematological worldwide network. The 13th joint session with the American Society of Hematology (ASH) will focus on a policy related issue faced by many hematologists. While the symposium with the Japanese Society of Hematology (JSH) chooses a specific disease and the possible differences between the European and Japanese approach. The well-established doctor-patient communication oriented session of the European School of Haematology (ESH) will be included again in the program but has been moved to the Saturday lunch time slot.
The highly successful Laboratory Hematology Workshop and Molecular Hemopoiesis Workshop will return as well in the program on respectively Friday morning and afternoon.
The 4th repetition of the Laboratory Hematology Workshop on Friday morning (08:00 - 11:15) covers the progress in diagnostic work. Three sessions adress key tools of laboratory hematology:
- Advances in the classification of mature B-cell and plasma cell malignancies;
- Diagnosis and classification of mature T-cell malignancies;
- Rare hematological disorders.
The Molecular Hemopoiesis Workshop consists of the following three sessions:
- Apoptosis & Signalling
- Normal & leukemic stem cells
- Transcription & epigenetics